Pyrimidine amide compounds as PGDS inhibitors

This invention is directed to a compound of formula (I): wherein R, R, R and L are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chr...

Full description

Saved in:
Bibliographic Details
Main Authors MU, LAN, THURAIRATNAM, SUKANTHINI, MA, LIANG, MUNSON, HARRY RANDALL, JIANG, JOHN ZIQI, SABOL, JEFFREY STEPHEN, ALDOUS, SUZANNE C, LU, JINQI, VANDEUSEN, CHRISTOPHER LOREN
Format Patent
LanguageEnglish
Published 26.04.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention is directed to a compound of formula (I): wherein R, R, R and L are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
Bibliography:Application Number: AU20060299428